833 abstracts found.



Results filter

Patterns of colorectal cancer recurrence over 5-years: a longitudinal study.

Year:

Session type:

Luis Daverede1, Alex Newsham1, Mehran Afshar1, Lucy Walkington1, Peter Hall1, James Thomas1, David Sebag-Montefiore1, P Finan1, G Radhakrishna1, Fiona Collinson1, Geoff Hall1, Adam Glaser1
1St. James Institute of Oncology, Leeds, UK

Mammographic breast density, body mass index, age and breast cancer risk: findings from the placebo arm of the International Breast Cancer Intervention Study-I

Year:

Session type:

Jane Warwick1, Hanna Birke2, Jennifer Stone3, Ruth ML Warren4, Elizabeth Pinney2, Stephen W Duffy2, Anthony Howell5, Jack Cuzick2
1Imperial College London, London, UK, 2Queen Mary University of London, London, UK, 3The University of Melbourne, Melbourne, Australia, 4Addenbrooke's Hospital, Cambridge, UK, 5The Christie NHS Trust, Manchester, UK

Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking.

Year:

Session type:

Natalie Shenker1, Silvia Polidoro2, Karin van Veldhoven1, Carlotta Sacerdote2, Fulvio Ricceri2, Mark Birrell1, Maria Belvisi1, Robert Brown1, Paolo Vineis1,2, James Flanagan1
1Imperial College London, London, UK, 2HuGeF Foundation, Torino, Italy

Methylation profiling to characterise the progression of Nephrogenic rests to Wilms tumour

Year:

Session type:

Jocelyn Charlton1, Richard Williams1, Tiffany Morris2, Kerra Pearce3, Marisa Alcaide-German1, Tasnim Chagtai1, Sergey Popov4, Neil Sebire1, Gordan Vujanic5, Stephan Beck1, Kathy Pritchard-Jones1
1Department of Molecular Haematology and Cancer Biology, Institute of Child Health, UCL, London, UK, 2Medical Genomics, UCL Cancer Institute, UCL, London, UK, 3UCL Genomics, Institute of Child Health, UCL, London, UK, 4Divisions of Molecular Pathology and Cancer Therapeutics, Institute of Cancer Research, Surrey, UK, 5Department of Histopathology, School of Medicine, Cardiff University, Cardiff, UK

Identification of Resveratrol-Binding Proteins using Affinity Purification and capLC-MS/MS

Year:

Session type:

Christina Ann Kurian1, Robert G. Britton1, Emma Horner-Glister1, Rebekah Jukes-Jones2, Kelvin Cain2, William Steward1, Andreas Gescher1, Karen Brown1
1University of Leicester, Leicester, UK, 2MRC Toxicology Unit, Leicester, UK

Quantifying the costs of colorectal cancer: the importance of considering different perspectives

Year:

Session type:

Paul Hanly1, Alan O'Ceilleachair1, Mairead Skally1, Ciaran O'Neill2, Kanika Kapur3, Patricia Fitzpatrick3, Anthony Staines4, Linda Sharp1
1National Cancer Registry, Cork, Ireland, 2National University of Ireland, Galway, Ireland, 3University College Dublin, Dublin, Ireland, 4Dublin City University, Dublin, Ireland

Using the National Cancer Data Repository to measure long term clinical outcomes – data from the MRC CR07 trial

Year:

Session type:

Eva Morris1,3, Louise Whitehouse1,3, James Thomas2, Phil Quirke1, Lindsay Thompson2, John Wilkinson3, David Sebag-Montefiore1
1University of Leeds, Leeds, UK, 2MRC Clinical Trial Unit, London, UK, 3Northern & Yorkshire Cancer Registry & Information Service, Leeds, UK

Logarithmic dose banding (LDB) of chemotherapy for cancer patients

Year:

Session type:

Geoff Hall1, Jenny Seligmann1, Graham Marsh2, Burhan Zavery3, Chris Twelves1
1St James's Institute of Oncology, Leeds, UK, 2Weston Park Hospital, Sheffield, UK, 3Mid Cheshire Hospitals NHS Foundation Trust, Crewe, UK

In Vitro Metastatic Niche Models to study Breast Cancer Cell Dormancy and Proliferation in the Bone Marrow

Year:

Session type:

Rebecca Marlow1, Massimiliano Cariati1, Gabriella Honeth1, Bharath Buchupalli1, Sara Lombardi1, Katie Foster2, Dominique Bonnet2, Arnie Purushotham1, Andrew Tutt1, Gabriela Dontu1
1King's College London, London, UK, 2Cancer Research UK, London, UK

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control

Year:

Session type:

Emanuele de Rinaldis1, Brian Burford1, Patricia Gazinska1, Anca Mera1, Zora Modrusan3, Grazyna M. Fedorowicz3, Cheryl Gillett4, Pierfrancesco Marra1, Anita Grigoriadis1, David Dornan5, Lars Homberg2, Sarah Pinder4, Andrew Tutt1
1Breakthrough Breast Cancer Research Unit, King's College London School of Medicine, Guy's Hospital, London, UK, 2King's College London School of Medicine, London, UK, 3Department of Molecular Biology, Genentech, Inc.,, South San Francisco, USA, 4Breast Research Pathology, Research Oncology, King's College London, Guy's Hospital, London, UK, 5Department of Molecular Diagnostics and Cancer Cell Biology, Genentech, Inc., South San Francisco, USA

Page 25 of 84« First...25...50...Last »